iBio, Inc. SEC filings IBIO

iBio, Inc. has 909 filings in SEC EDGAR's recent list, going back to Mar 7, 2008. Its latest annual report, Form ARS, was filed on Sep 4, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 12, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on June 30.

Form Description Filed Period
10-Q Quarterly report May 12, 2026 Mar 31, 2026
10-Q Quarterly report Feb 10, 2026 Dec 31, 2025
10-Q/A Amended quarterly report Nov 17, 2025 Sep 30, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
10-Q Quarterly report May 2, 2025 Mar 31, 2025
10-Q Quarterly report Feb 10, 2025 Dec 31, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
10-Q Quarterly report Feb 9, 2024 Dec 31, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q/A Amended quarterly report May 19, 2023 Dec 31, 2022
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
10-Q Quarterly report May 15, 2020 Mar 31, 2020
10-Q Quarterly report Feb 14, 2020 Dec 31, 2019
10-Q Quarterly report Nov 14, 2019 Sep 30, 2019
10-Q Quarterly report May 10, 2019 Mar 31, 2019
10-Q Quarterly report Feb 13, 2019 Dec 31, 2018
10-Q Quarterly report Nov 13, 2018 Sep 30, 2018
10-Q Quarterly report May 11, 2018 Mar 31, 2018
10-Q Quarterly report Feb 14, 2018 Dec 31, 2017
10-Q Quarterly report Nov 9, 2017 Sep 30, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
10-Q Quarterly report Feb 21, 2017 Dec 31, 2016
10-Q Quarterly report Nov 18, 2016 Sep 30, 2016
10-Q Quarterly report May 23, 2016 Mar 31, 2016
10-Q Quarterly report Feb 22, 2016 Dec 31, 2015
10-Q Quarterly report Nov 13, 2015 Sep 30, 2015
10-Q Quarterly report May 15, 2015 Mar 31, 2015
10-Q/A Amended quarterly report Feb 24, 2015 Dec 31, 2014
10-Q Quarterly report Feb 23, 2015 Dec 31, 2014
10-Q Quarterly report Nov 14, 2014 Sep 30, 2014
10-Q Quarterly report May 15, 2014 Mar 31, 2014
10-Q Quarterly report Feb 14, 2014 Dec 31, 2013
10-Q Quarterly report Nov 14, 2013 Sep 30, 2013
10-Q Quarterly report May 20, 2013 Mar 31, 2013
10-Q Quarterly report Feb 19, 2013 Dec 31, 2012
10-Q Quarterly report Nov 14, 2012 Sep 30, 2012
10-Q Quarterly report May 15, 2012 Mar 31, 2012
10-Q Quarterly report Feb 14, 2012 Dec 31, 2011
10-Q Quarterly report Nov 14, 2011 Sep 30, 2011
10-Q Quarterly report May 18, 2011 Mar 31, 2011
10-Q Quarterly report Feb 14, 2011 Dec 31, 2010
10-Q Quarterly report Nov 15, 2010 Sep 30, 2010
10-Q Quarterly report May 19, 2010 Mar 31, 2010
10-Q/A Amended quarterly report Feb 17, 2010 Sep 30, 2009
10-Q Quarterly report Feb 16, 2010 Dec 31, 2009
10-Q Quarterly report Nov 16, 2009 Sep 30, 2009
10-Q Quarterly report May 15, 2009 Mar 31, 2009
10-Q Quarterly report Feb 11, 2009 Dec 31, 2008
10-Q Quarterly report Nov 12, 2008 Sep 30, 2008

Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IBIO (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1420720
Former names
iBio, Inc. (until Oct 19, 2026); iBioPharma, Inc. (until Aug 14, 2009); InB:Biotechnologies, Inc. (until Jul 17, 2008)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.